EYEGATE PHARMACEUTICALS INC's ticker is EYEG and the CUSIP is 30233M107. A total of 23 filers reported holding EYEGATE PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $3,000 | -25.0% | 12,355 | 0.0% | 0.00% | – |
| Q1 2019 | $4,000 | -33.3% | 12,355 | 0.0% | 0.00% | – |
| Q4 2018 | $6,000 | +50.0% | 12,355 | 0.0% | 0.00% | – |
| Q3 2018 | $4,000 | -42.9% | 12,355 | 0.0% | 0.00% | – |
| Q2 2018 | $7,000 | +40.0% | 12,355 | -0.0% | 0.00% | – |
| Q1 2018 | $5,000 | – | 12,356 | +1235500.0% | 0.00% | – |
| Q4 2017 | $0 | – | 1 | 0.0% | 0.00% | – |
| Q3 2017 | $0 | – | 1 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 16,802,500 | $5,209,000 | 0.31% |
| WEDBUSH SECURITIES INC | 20,000 | $6,000 | 0.00% |
| US BANCORP \DE\ | 40,650 | $13,000 | 0.00% |
| WELLS FARGO & COMPANY/MN | 100 | $0 | 0.00% |
| NORTHERN TRUST CORP | 14,553 | $5,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 44,270 | $14,000 | 0.00% |
| PANAGORA ASSET MANAGEMENT INC | 107,430 | $33,000 | 0.00% |
| MORGAN STANLEY | 5,000 | $2,000 | 0.00% |
| Invesco Ltd. | 10,323 | $3,000 | 0.00% |